Cabaletta Bio, Inc. SEC filings CABA
Cabaletta Bio, Inc. has 448 filings in SEC EDGAR's recent list, going back to Dec 10, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 4, 2026 | — |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Jun 12, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| POS AM | Filing | Mar 31, 2025 | — |
| S-3ASR | Automatic shelf registration | Mar 21, 2024 | — |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| S-8 | Employee stock plan registration | Aug 10, 2023 | — |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| S-3 | Shelf registration | Mar 16, 2023 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| 424B5 | Prospectus supplement | Dec 8, 2022 | — |
| FWP | Free writing prospectus | Dec 8, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| S-3 | Shelf registration | Nov 10, 2020 | — |
| S-8 | Employee stock plan registration | Mar 30, 2020 | — |
| S-8 | Employee stock plan registration | Oct 29, 2019 | — |
| 424B4 | Prospectus | Oct 25, 2019 | — |
| S-1MEF | Filing | Oct 24, 2019 | — |
| S-1/A | Amended registration statement | Oct 16, 2019 | — |
| S-1 | Registration statement | Sep 30, 2019 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CABA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1759138
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.